GLP-1 Market
LLY $1170.14 ▲ +0.5% NVO $39.40 ▼ -1.0% PFE $27.93 ▲ +0.7% VKTX $40.85 ▲ +35.7% KLRA $12.79 ▲ +6.7% GPCR $36.91 ▲ +0.3% RHHBY $55.56 ▲ +0.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Moxifloxacin Hydrochloride

Company
Amgen
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
17 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

17 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 23, 2026

Find a Clinical Trial Near Me

See recruiting studies for Moxifloxacin Hydrochloride and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03625739

    Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis

    Beijing Children's Hospital 800 participants Est. completion 2026-12-31 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT04722978

    Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

    Not yet reported Sun Yat-Sen University Cancer Center 228 participants Est. completion 2026-07 1 site
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05081401

    Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

    Not yet reported Huashan Hospital 1050 participants Est. completion 2027-12-01 5 sites Stand-alone
    Other conditions: Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB
    View official trial listing →
  • Recruiting NCT NCT05381194

    BPaL(M) Regimen for the Treatment of MDR/RR-TB

    Not yet reported Asan Medical Center 80 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Multidrug- and Rifampicin-resistant Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT05398679

    Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 360 participants Est. completion 2027-12-30 20 sites Stand-alone
    Other conditions: Endocarditis Infective
    View official trial listing →
  • Recruiting NCT NCT05807399

    PanACEA - STEP2C -01

    Not yet reported Michael Hoelscher 390 participants Est. completion 2027-12-30 10 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT05821478

    Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients

    Not yet reported Institut Pasteur 92 participants Est. completion 2028-02-27 4 sites Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Recruiting NCT NCT05902221

    Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

    Not yet reported Centre Hospitalier Universitaire de Nice 235 participants Est. completion 2028-05 13 sites Stand-alone
    Other conditions: Infections Joint Prosthetic
    View official trial listing →
  • Recruiting NCT NCT06186271

    International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)

    Center for Epidemiology and Health Research, Germany 68100 participants Est. completion 2029-06 1 site
    Other conditions: Contraception
    View official trial listing →
  • Recruiting NCT NCT06423898

    Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 284 participants Est. completion 2028-12-31 18 sites
    Other conditions: Endocarditis, Infective
    View official trial listing →
  • Recruiting NCT NCT06441006

    Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

    Not yet reported, Not yet reported University of California, San Francisco 400 participants Est. completion 2031-08 6 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR
    View official trial listing →
  • Recruiting NCT NCT06537609

    A Platform Trial for Gram Negative Bloodstream Infections

    Not yet reported Sunnybrook Health Sciences Centre 2500 participants Est. completion 2028-04 39 sites
    Other conditions: Gram-negative Bacteremia
    View official trial listing →
  • Recruiting NCT NCT07162116

    A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants

    Not yet reported Shijiazhuang Yiling Pharmaceutical Co. Ltd 45 participants Est. completion 2026-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation
    View official trial listing →
  • Recruiting NCT NCT07170800

    A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

    Not yet reported WestVac Biopharma Co., Ltd. 60 participants Est. completion 2026-09-04 7 sites Stand-alone
    Other conditions: Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT07209761

    A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 532 participants Est. completion 2028-09-29 35 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Recruiting NCT NCT07212803

    Effects of Energy Drinks on Cardiovascular Endpoints

    Not yet reported University of the Pacific 3 participants Est. completion 2026-09 1 site
    Other conditions: Healthy Volunteers, Safety After Oral Intake
    View official trial listing →
  • Recruiting NCT NCT07305987

    PRO-232 in Patients Subjected to Cataract Surgery

    Not yet reported Laboratorios Sophia S.A de C.V. 134 participants Est. completion 2026-07-30 2 sites Stand-alone
    Other conditions: Cataract Extraction
    View official trial listing →
  • Completed NCT NCT00042289

    Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

    National Institute of Allergy and Infectious Diseases (NIAID) 1578 participants Est. completion 2020-09-30 62 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00082173

    Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis

    Not yet reported Johns Hopkins University 170 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00140309

    TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

    Not yet reported Centers for Disease Control and Prevention 350 participants Est. completion 2005-12 23 sites
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT00158093

    A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

    Not yet reported Mylan Bertek Pharmaceuticals 260 participants Est. completion 2003-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00164463

    TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment

    Not yet reported Centers for Disease Control and Prevention 72 participants Est. completion 2007-08 8 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00174512

    A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade

    Not yet reported Pfizer 36 participants Est. completion 2006-06 6 sites
    Other conditions: Patients With Pace Makers But no Evidence of Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00199225

    Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers

    Not yet reported J. Uriach and Company 160 participants Est. completion 2005-07 1 site
    Other conditions: Human Experimentation (Human Volunteers)
    View official trial listing →
  • Completed NCT NCT00257452

    A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®)

    Not yet reported Boehringer Ingelheim 56 participants Est. completion 2005-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00280514

    Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration

    Not yet reported Medical University of Vienna 20 participants Est. completion 2009-12 1 site
    Other conditions: Abscess, Cysts
    View official trial listing →
  • Completed NCT NCT00292227

    Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

    Not yet reported UCB Pharma 130 participants Est. completion 2006-10 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT00301587

    A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Est. completion 2004-12
    Other conditions: Neural Tube Defects, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nervous System Malformations
    View official trial listing →
  • Completed NCT NCT00306319

    Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia

    Not yet reported Radboud University Medical Center 23 participants Est. completion 2006-05 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00310596

    Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects

    Not yet reported Bayer 71 participants Est. completion 2004-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00312338

    Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

    Not yet reported Alcon Research 137 participants Est. completion 2007-06 1 site
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00316459

    Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 64 participants 1 site
    Other conditions: Healthy, Long QT Syndrome
    View official trial listing →
  • Completed NCT NCT00320567

    The Effect of Norgestimate/Ethinyl Estradiol on Bone Density in Pediatric Subjects With Anorexia Nervosa

    Not yet reported McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 123 participants Est. completion 2004-04
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00323219

    Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

    Not yet reported University of British Columbia 390 participants Est. completion 2013-12 1 site
    Other conditions: Cellulitis
    View official trial listing →
  • Completed NCT NCT00324168

    Steroids for Corneal Ulcers Trial

    Not yet reported Thomas M. Lietman 500 participants Est. completion 2012-12 5 sites
    Other conditions: Corneal Ulcer, Eye Infections, Bacterial
    View official trial listing →
  • Terminated NCT NCT00324324

    Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

    Not yet reported OHSU Knight Cancer Institute 240 participants Est. completion 2012-12 1 site
    Other conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00331084

    Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Postoperative Inflammation in Cataract Surgery

    Not yet reported Federal University of São Paulo 132 participants Est. completion 2007-03 1 site
    Other conditions: Inflammation Following Cataract Surgery
    View official trial listing →
  • Completed NCT NCT00332293

    AL-15469A for the Treatment of Bacterial Conjunctivitis

    Not yet reported Alcon Research 695 participants Est. completion 2006-12 1 site Stand-alone
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Status unknown NCT NCT00335088

    Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations

    Not yet reported HaEmek Medical Center, Israel 500 participants Est. completion 2007-05 1 site
    Other conditions: Eye Infections
    View official trial listing →
  • Status unknown NCT NCT00347828

    Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

    Not yet reported Ophthalmic Consultants of Boston 40 participants Est. completion 2006-06 1 site
    Other conditions: Eye Infection, Infection
    View official trial listing →
  • Completed NCT NCT00348348

    A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

    Not yet reported Bausch & Lomb Incorporated 1161 participants Est. completion 2007-07
    Other conditions: Acute Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00357604

    Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2006-11 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00396084

    Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 70 participants Est. completion 2007-12-28 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00398411

    Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

    Not yet reported University of Cologne 66 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Hodgkin Disease, Non-Hodgkin Lymphoma, Multiple Myeloma, Bacteremia
    View official trial listing →
  • Completed NCT NCT00399685

    Drug Interaction - Oral Contraceptive

    Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2007-08 2 sites
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00402727

    Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

    Not yet reported Bayer 813 participants Est. completion 2008-06 123 sites Stand-alone
    Other conditions: Abscess, Wound Infection, Diabetic Foot, Ulcer
    View official trial listing →
  • Completed NCT NCT00407017

    Therapeutic Variables in Cataract Surgery

    Not yet reported Innovative Medical 1 site
    Other conditions: Cataract Surgery
    View official trial listing →
  • Completed NCT NCT00411073

    Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart

    Not yet reported GlaxoSmithKline 72 participants 1 site
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00414011

    Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

    Not yet reported Walter Reed Army Medical Center 40 participants Est. completion 2005-02 1 site Stand-alone
    Other conditions: Epithelium, Corneal
    View official trial listing →
  • Completed NCT NCT00431678

    Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

    Not yet reported Bayer 738 participants Est. completion 2005-07 95 sites Stand-alone
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT00434395

    Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

    Not yet reported Bausch Health Americas, Inc. Est. completion 2007-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00437242

    Odiparcil QT Definitive Study

    Not yet reported GlaxoSmithKline 54 participants 1 site
    Other conditions: Fibrillation, Atrial, Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT00439972

    Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity

    Not yet reported University of Washington 36 participants Est. completion 2011-12 1 site
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00447304

    Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy

    Not yet reported Heidelberg University 644 participants Est. completion 2010-12 1 site
    Other conditions: Acute Cholecystitis
    View official trial listing →
  • Completed NCT NCT00447629

    Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00455806

    Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection

    Not yet reported Technische Universität Dresden 132 participants Est. completion 2008-02 9 sites
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Terminated NCT NCT00460759

    Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

    Not yet reported Johns Hopkins University 15 participants Est. completion 2008-08-24 1 site Stand-alone
    Other conditions: Mycobacterium Tuberculosis
    View official trial listing →
  • Completed NCT NCT00464438

    A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis

    Not yet reported Allergan 171 participants Est. completion 2008-09 2 sites
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Withdrawn NCT NCT00466570

    Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application

    Not yet reported Stanford University
    Other conditions: Conjunctical Flora
    View official trial listing →
  • Completed NCT NCT00485667

    Phase 1 Thorough QT Study in Young Healthy Volunteers

    Not yet reported Pacira Pharmaceuticals, Inc 48 participants Est. completion 2007-08 1 site Stand-alone
    Other conditions: Postoperative Pain
    View official trial listing →
  • Completed NCT NCT00492024

    BAY12-8039: 5 Days for Sinusitis vs Placebo

    Not yet reported Bayer 374 participants Est. completion 2008-03 51 sites Stand-alone
    Other conditions: Sinusitis
    View official trial listing →
  • Completed NCT NCT00492726

    Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

    Not yet reported Bayer 804 participants Est. completion 2009-02 52 sites Stand-alone
    Other conditions: Infection
    View official trial listing →
  • Terminated NCT NCT00493038

    Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

    Not yet reported Bayer 293 participants Est. completion 2008-01 34 sites Stand-alone
    Other conditions: Sinusitis, Bacterial Infections
    View official trial listing →
  • Completed NCT NCT00499642

    Study Evaluating the Effect of Lecozotan SR on the QTc Interval

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2007-08 2 sites
    Other conditions: Alzheimer Disease, Healthy
    View official trial listing →
  • Completed NCT NCT00531791

    Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation

    Not yet reported Laval University 14 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00534287

    Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic Shock

    Not yet reported Kompetenznetz Sepsis 600 participants Est. completion 2010-06 52 sites
    Other conditions: Severe Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT00537563

    AMS VS MOXI Ketek vs Avelox in AMS

    Not yet reported Sanofi 351 participants Est. completion 2003-09 1 site
    Other conditions: Maxillary Sinusitis
    View official trial listing →
  • Completed NCT NCT00543062

    Staccato Prochlorperazine Thorough QT/QTc

    Not yet reported Alexza Pharmaceuticals, Inc. 48 participants Est. completion 2007-12 1 site
    Other conditions: Cardiotoxicity
    View official trial listing →
  • Completed NCT NCT00549666

    A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

    Not yet reported Sumitomo Pharma America, Inc. 23 participants Est. completion 2007-12 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00554632

    Birth Control Pill vs Birth Control Patch Study

    Not yet reported University of Vermont 24 participants Est. completion 2005-08
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00564447

    Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

    Not yet reported Merck Sharp & Dohme LLC 48 participants Stand-alone
    Other conditions: Bacterial Infections, Eye Infections
    View official trial listing →
  • Withdrawn NCT NCT00565630

    Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops

    Not yet reported Advanced Ophthalmic Pharma 16 participants Est. completion 2008-03
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT00569881

    Effect of Topical Fluoroquinolones on Epithelial Wound Healing After PRK

    Donnenfeld, Eric, M.D. 22 participants Est. completion 2007-03
    Other conditions: Corneal Epithelial Wound Healing
    View official trial listing →
  • Completed NCT NCT00575367

    Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers

    Not yet reported Merck Sharp & Dohme LLC 37 participants 1 site
    Other conditions: Bacterial Infections, Eye Infections
    View official trial listing →
  • Completed NCT NCT00575380

    Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery

    Not yet reported Merck Sharp & Dohme LLC 116 participants 13 sites
    Other conditions: Bacterial Infections, Eye Infections, Cataract Extraction
    View official trial listing →
  • Completed NCT NCT00578773

    A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

    Not yet reported Alcon Research 303 participants Est. completion 2009-01
    Other conditions: Acute Otitis Media
    View official trial listing →
  • Completed NCT NCT00579189

    Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes

    Not yet reported Alcon Research 776 participants Est. completion 2009-01
    Other conditions: Acute Otitis Media
    View official trial listing →
  • Completed NCT NCT00581542

    Moxifloxacin vs. Polytrim for Conjunctivitis

    Not yet reported University of Rochester 124 participants Est. completion 2012-03 1 site
    Other conditions: Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00629135

    Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses

    Not yet reported Hannover Medical School 180 participants Est. completion 2011-08-15 1 site Stand-alone
    Other conditions: Abscess, Intra-Abdominal
    View official trial listing →
  • Completed NCT NCT00630019

    Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator

    Not yet reported Santen Inc. 96 participants 1 site
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT00665327

    Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

    Not yet reported Bayer 401 participants Est. completion 2004-04 77 sites Stand-alone
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT00666042

    Bioequivalence of Eye Drops and Spray Administration of Vigamox

    Not yet reported Advanced Ophthalmic Pharma 16 participants Est. completion 2009-05 1 site
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT00672399

    Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects

    Not yet reported AstraZeneca 70 participants Est. completion 2008-07 2 sites Added to GLP-1
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00675701

    A Study to Define the ECG Effects of Lixivaptan Compared to Placebo and Moxifloxacin in Healthy Adult Men and Women: A Thorough ECG Study

    Not yet reported CardioKine Inc. 298 participants Est. completion 2008-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00688493

    Effects of Single Oral Dose Dapagliflozin QT Study

    Not yet reported AstraZeneca 36 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00699504

    Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers

    Not yet reported The Medicines Company 67 participants Est. completion 2008-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00703313

    Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators

    Not yet reported Santen Inc. 72 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00708903

    Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

    Not yet reported Puma Biotechnology, Inc. 60 participants Est. completion 2008-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00709332

    A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-02
    Other conditions: Drug Interactions, Contraception, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00709644

    Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54 participants Est. completion 2005-08
    Other conditions: Pharmacokinetics, Therapeutic Equivalency, Contraceptives, Oral
    View official trial listing →
  • Completed NCT NCT00709982

    A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-07
    Other conditions: Drug Interactions, Healthy, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00713336

    Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval

    Not yet reported AstraZeneca 40 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00717561

    A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia

    Not yet reported Bayer 60 participants Est. completion 2009-06 23 sites Stand-alone
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT00721344

    A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

    Not yet reported Mannkind Corporation 48 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00744809

    TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

    Not yet reported Tibotec Pharmaceuticals, Ireland 120 participants Est. completion 2009-01
    Other conditions: Human Volunteers
    View official trial listing →
  • Completed NCT NCT00750633

    A Phase III Study of an Otic Formulation in Acute Otitis Externa

    Not yet reported Alcon Research 990 participants Est. completion 2009-01
    Other conditions: Acute Otitis Externa
    View official trial listing →
  • Completed NCT NCT00752635

    Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris

    Not yet reported Johnson & Johnson Taiwan Ltd 48 participants Est. completion 2005-09
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Status unknown NCT NCT00752947

    Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors

    Not yet reported Beijing Hospital 186 participants Est. completion 2010-05 2 sites Stand-alone
    Other conditions: Community-Acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT00754065

    To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)

    Not yet reported Bayer 409 participants Est. completion 2011-05-10 59 sites
    Other conditions: Contraception
    View official trial listing →
  • Completed NCT NCT00758199

    Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

    Not yet reported Bp Consulting, Inc 49 participants Est. completion 2010-01 1 site
    Other conditions: Cataracts
    View official trial listing →
  • Completed NCT NCT00759148

    Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

    Not yet reported Alcon Research 1179 participants Est. completion 2010-03 Stand-alone
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00769041

    A Thorough EKG Safety Study of TA-1790 (Avanafil)

    Not yet reported VIVUS LLC 57 participants Est. completion 2009-01 1 site
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT00769171

    Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)

    Not yet reported Bayer 364 participants Est. completion 2007-01 25 sites Stand-alone
    Other conditions: Infection, Intra-abdominal
    View official trial listing →
  • Completed NCT NCT00795145

    A Study To Assess The Effect Of Linezolid On QTc Interval

    Not yet reported Pfizer 49 participants Est. completion 2009-03 1 site
    Other conditions: Bacterial Infections
    View official trial listing →
  • Completed NCT NCT00798577

    Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment

    Not yet reported Alcon Research 24 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00805558

    Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis

    Not yet reported Facultad Nacional de Salud Publica 76 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Chronic Periodontitis
    View official trial listing →
  • Completed NCT NCT00816426

    Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2017-12-29 3 sites
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT00824070

    Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects

    Not yet reported Bausch & Lomb Incorporated 105 participants Est. completion 2009-08 1 site
    Other conditions: Cataract Extraction
    View official trial listing →
  • Completed NCT NCT00828971

    A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs

    Not yet reported Bayer 16 participants Est. completion 2009-10 22 sites Stand-alone
    Other conditions: Infectious Diseases
    View official trial listing →
  • Completed NCT NCT00831961

    Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics

    Vanderbilt University 24 participants 1 site
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00839891

    A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

    Not yet reported VIVUS LLC 112 participants Est. completion 2009-04 1 site
    Other conditions: Torsades de Pointes
    View official trial listing →
  • Completed NCT NCT00840580

    Effect on Wound Healing of Vigamox Versus Cravit

    Not yet reported Alcon Research 79 participants 1 site Stand-alone
    Other conditions: Cataract Extraction
    View official trial listing →
  • Completed NCT NCT00861029

    VEG111485: A QTc Study of Pazopanib

    Not yet reported GlaxoSmithKline 2 participants Est. completion 2010-02-15 8 sites Stand-alone
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00870103

    Study of Efficacy and Safety of Vigadexa in Treating Inflammation and Infection Post-cataract Surgery

    Not yet reported Alcon Research 64 participants 1 site Stand-alone
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT00874237

    Staccato Loxapine Thorough QT/QTc Study

    Not yet reported Nova Pneuma Inc. 48 participants Est. completion 2009-06 1 site
    Other conditions: Thorough QT/QTc Study
    View official trial listing →
  • Completed NCT NCT00874887

    A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

    Not yet reported Allergan 66 participants Est. completion 2009-10 2 sites
    Other conditions: Anti-biotic Resistance
    View official trial listing →
  • Completed NCT NCT00876577

    VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis

    Bayer 1206 participants Est. completion 2011-03 1 site
    Other conditions: Chronic Bronchitis, Disease Exacerbation
    View official trial listing →
  • Withdrawn NCT NCT00876850

    Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

    Not yet reported Paratek Pharmaceuticals Inc Est. completion 2010-08
    Other conditions: Skin Structures and Soft Tissue Infections
    View official trial listing →
  • Completed NCT NCT00879008

    SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)

    Bayer 345 participants Est. completion 2010-08 1 site
    Other conditions: Chronic Bronchitis
    View official trial listing →
  • Completed NCT NCT00887770

    A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart

    Not yet reported AstraZeneca 64 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00892918

    Effect of Moxifloxacin Versus Gatifloxacin on Corneal Epithelium Following Pterygium Excision

    Not yet reported Meir Medical Center 40 participants Est. completion 2010-06 1 site
    Other conditions: Primary Pterygium
    View official trial listing →
  • Suspended NCT NCT00901290

    Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

    Not yet reported AstraZeneca 56 participants Est. completion 2009-09 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00905762

    Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation

    Not yet reported Bausch & Lomb Incorporated 119 participants Est. completion 2009-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00914121

    Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2009-08 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00924729

    Study of Ocular Penetration of Topically Administered Fluoroquinolones

    Not yet reported Johns Hopkins University 50 participants Est. completion 2009-11 1 site
    Other conditions: Cataract Extraction
    View official trial listing →
  • Terminated NCT NCT00926263

    A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects

    Not yet reported Pfizer 28 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00930488

    Treatment of Patients With Acute Sinusitis

    Bayer 6777 participants Est. completion 2008-12 19 sites
    Other conditions: Acute Bacterial Sinusitis
    View official trial listing →
  • Completed NCT NCT00936871

    The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects

    Not yet reported Pfizer 66 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00952796

    A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 100 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Intra-abdominal Infection
    View official trial listing →
  • Completed NCT NCT00964730

    A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 135 participants Est. completion 2010-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00973388

    VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

    Not yet reported Tibotec BVBA 44 participants Est. completion 2010-01
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00983957

    Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects

    Not yet reported Bristol-Myers Squibb 47 participants Est. completion 2010-02 3 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00987792

    CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

    Bayer 2595 participants Est. completion 2012-10 11 sites
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT00996021

    Study to Assess Cardiac Conduction of GSK1349572

    Not yet reported GlaxoSmithKline 42 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT00997997

    Avelox in Complicated Skin and Skin Structure Infections

    Bayer 6127 participants Est. completion 2008-12 12 sites
    Other conditions: Skin Diseases, Bacterial
    View official trial listing →
  • Completed NCT NCT01017731

    Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

    Not yet reported Eli Lilly and Company 68 participants Est. completion 2014-05 7 sites Stand-alone
    Other conditions: Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT01018420

    Pharmacokinetic and Exploratory Electrocardiogram (ECG) Study

    Not yet reported Mutual Pharmaceutical Company, Inc. 18 participants Est. completion 2008-01 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT01024322

    Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas

    Cxlusa 1189 participants Est. completion 2017-02-03 3 sites
    Other conditions: Keratoconus, Ectasia, Degeneration
    View official trial listing →
  • Completed NCT NCT01045902

    BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

    Not yet reported Bayer 139 participants Est. completion 2005-01 15 sites Stand-alone
    Other conditions: Pneumonia, Aspiration, Lung Abscess
    View official trial listing →
  • Completed NCT NCT01049022

    Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

    Not yet reported Bayer 31 participants Est. completion 2013-08 11 sites Stand-alone
    Other conditions: Infections
    View official trial listing →
  • Terminated NCT NCT01055145

    Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients

    Not yet reported Seoul National University Hospital 182 participants Est. completion 2012-10 29 sites
    Other conditions: TB
    View official trial listing →
  • Completed NCT NCT01063023

    Drug Interaction Oral Contraceptive Pill (OCP)

    Not yet reported Bristol-Myers Squibb 20 participants Est. completion 2010-06 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Terminated NCT NCT01071902

    Safety and Efficacy of Moxidex Otic

    Not yet reported Alcon Research 400 participants Est. completion 2011-10 1 site
    Other conditions: Acute Otitis Media
    View official trial listing →
  • Completed NCT NCT01090661

    A Study to Evaluate the Effect of Mipomersen on Cardiac Repolarization Conducted in Healthy Subjects

    Not yet reported Kastle Therapeutics, LLC 60 participants Est. completion 2010-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01091493

    Antibiotic or Not in Non-purulent Exacerbations of COPD: a Trial of Security and Efficacy

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 73 participants Est. completion 2018-07-05 4 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01096511

    Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)

    Bayer 1001 participants Est. completion 2011-01 1 site
    Other conditions: Secondary Peritonitis, Abscess, Intra-Abdominal
    View official trial listing →
  • Terminated NCT NCT01097447

    Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas (2)

    Cxlusa 2619 participants Est. completion 2017-04-30 5 sites
    Other conditions: Keratoconus, Ectasia, Degeneration
    View official trial listing →
  • Completed NCT NCT01103830

    Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers

    Not yet reported sigma-tau i.f.r. S.p.A. 287 participants Est. completion 2010-12 1 site
    Other conditions: Malaria, Falciparum
    View official trial listing →
  • Completed NCT NCT01107054

    A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

    Not yet reported Pfizer 48 participants Est. completion 2010-12 1 site
    Other conditions: Pulmonary Disease, Lung Disease, Moxifloxacin
    View official trial listing →
  • Completed NCT NCT01130922

    Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass

    Not yet reported University Ghent 12 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Gastric Bypass, Body Weight
    View official trial listing →
  • Completed NCT NCT01135680

    Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100

    Not yet reported Amgen 98 participants Est. completion 2010-09 1 site
    Other conditions: Drug Toxicity
    View official trial listing →
  • Completed NCT NCT01140425

    Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

    Not yet reported Pfizer 44 participants Est. completion 2010-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01148537

    The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

    Not yet reported Purdue Pharma LP 132 participants Est. completion 2004-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01154959

    Latency in Pulmonary Tuberculosis

    Not yet reported Tuberculosis Research Centre, India 120 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT01158755

    Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

    Not yet reported Universitas Padjadjaran 60 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Meningitis, Tuberculous, Pharmacokinetics, Pharmacodynamics, Tolerability
    View official trial listing →
  • Completed NCT NCT01173536

    A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

    Not yet reported Genentech, Inc. 61 participants Est. completion 2011-03-18
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Terminated NCT NCT01189864

    Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

    Cxlusa 3493 participants Est. completion 2017-02-03 16 sites
    Other conditions: Keratoconus, Ectasia, Degeneration
    View official trial listing →
  • Completed NCT NCT01191723

    QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo

    Not yet reported Allergan 54 participants Est. completion 2010-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01195675

    Assessment of the Effect of Empagliflozin (BI 10773) as Single Dose on the QT Interval in Healthy Female and Male Subjects

    Not yet reported Boehringer Ingelheim 30 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01209026

    Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

    Not yet reported GlaxoSmithKline 85 participants Est. completion 2011-01-04 1 site Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01215851

    Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

    Not yet reported Global Alliance for TB Drug Development 85 participants Est. completion 2011-08 2 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT01222442

    To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart

    Not yet reported AstraZeneca 40 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease, Lung Disease
    View official trial listing →
  • Completed NCT NCT01232413

    A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects

    Not yet reported Astellas Pharma Inc 88 participants Est. completion 2011-02 1 site
    Other conditions: Healthy Subjects, Cardiac Repolarization
    View official trial listing →
  • Completed NCT NCT01243580

    AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

    Not yet reported Agile Therapeutics 36 participants Est. completion 2009-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01265641

    To Investigate the Effects of AZD1981 on the QT Interval

    Not yet reported AstraZeneca 44 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01269294

    TMC435-TiDP16-C117: The Effect of TMC435 on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

    Not yet reported Tibotec Pharmaceuticals, Ireland 60 participants Est. completion 2011-07
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01296191

    Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification

    Not yet reported Frank A. Bucci, Jr., M.D. 120 participants Est. completion 2013-01 1 site
    Other conditions: Cataracts
    View official trial listing →
  • Completed NCT NCT01296542

    A Comparison of Prophylactic Antibacterial Efficacy of Besivance vs. VIGAMOX Prior to Cataract Surgery

    Not yet reported Bucci Laser Vision Institute 60 participants Est. completion 2013-01 1 site
    Other conditions: Cataracts
    View official trial listing →
  • Completed NCT NCT01297062

    A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects

    Not yet reported AstraZeneca 94 participants Est. completion 2011-05 2 sites
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01298336

    Treatment of Mycobacterium Xenopi Pulmonary Infection

    Not yet reported Centre Hospitalier Universitaire, Amiens 92 participants Est. completion 2019-03 52 sites Stand-alone
    Other conditions: Atypical; Mycobacterium, Pulmonary, Tuberculous
    View official trial listing →
  • Completed NCT NCT01302951

    Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.

    Not yet reported University Hospital, Saarland 34 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Side-effect of Antibiotic
    View official trial listing →
  • Completed NCT NCT01353729

    A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

    Not yet reported GlaxoSmithKline 40 participants Est. completion 2011-08-02 1 site Stand-alone
    Other conditions: Influenza, Human
    View official trial listing →
  • Terminated NCT NCT01359618

    Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

    Not yet reported AstraZeneca 16 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Healthy Male
    View official trial listing →
  • Completed NCT NCT01363323

    Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization

    Not yet reported Bausch Health Americas, Inc. 546 participants Est. completion 2005-02 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01373931

    A Study of LY2216684 in Healthy Females

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2011-12 1 site
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Completed NCT NCT01376076

    Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

    Not yet reported Forest Laboratories 129 participants Est. completion 2012-02 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01398072

    Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported University College, London 200 participants Est. completion 2013-04 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD).
    View official trial listing →
  • Completed NCT NCT01398293

    A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

    Not yet reported Hoffmann-La Roche 52 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01406262

    Albiglutide Thorough ECG Study in Healthy Volunteers

    Not yet reported GlaxoSmithKline 94 participants Est. completion 2011-12-29
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01423916

    Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 218 participants Est. completion 2012-03 8 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01458210

    A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants

    Not yet reported Eli Lilly and Company 22 participants Est. completion 2012-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01460368

    A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart

    Not yet reported Eli Lilly and Company 67 participants Est. completion 2012-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01461460

    A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects

    Not yet reported Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 48 participants Est. completion 2011-12-23 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01466673

    An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment

    Not yet reported Janssen-Cilag Ltd.,Thailand 201 participants Est. completion 2010-03 3 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT01487135

    Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects

    Not yet reported FORUM Pharmaceuticals Inc 60 participants Est. completion 2013-09
    Other conditions: Healthy Subjects, Cardiac Repolarization
    View official trial listing →
  • Completed NCT NCT01498419

    Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

    Not yet reported Global Alliance for TB Drug Development 207 participants Est. completion 2013-07 8 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT01511029

    Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

    Not yet reported Knopp Biosciences 68 participants Est. completion 2012-05 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Completed NCT NCT01514929

    A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

    Not yet reported Achaogen, Inc. 64 participants Est. completion 2012-03 1 site
    Other conditions: Cardiac Effects in Normal Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01516255

    Effect of Liraglutide on Heart Frequency in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 64 participants Est. completion 2006-11 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01516372

    A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

    Not yet reported XenoPort, Inc. 52 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT01518699

    Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers

    Not yet reported Dr. Reddy's Laboratories Limited 57 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Pediculosis
    View official trial listing →
  • Completed NCT NCT01525394

    A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

    Not yet reported Eisai Inc. 52 participants 1 site
    Other conditions: Refractory Solid Tumors, Lymphomas
    View official trial listing →
  • Completed NCT NCT01532115

    Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

    Not yet reported Bial - Portela C S.A. 64 participants Est. completion 2011-05 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01536951

    A Study of LY3009104 in Healthy Participants

    Not yet reported Eli Lilly and Company 62 participants Est. completion 2013-05 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT01537887

    A Study of LY2484595 on the Electrical Activity of the Heart

    Not yet reported Eli Lilly and Company 72 participants Est. completion 2012-06 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01546402

    Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 20 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Macular Edema, Cystoid, Vision Disorders, Diabetic Macular Edema, Cystoid Macular Edema Following Cataract Surgery, Cataract
    View official trial listing →
  • Completed NCT NCT01573910

    An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

    Not yet reported Alcon Research 985 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT01577342

    Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 56 participants Est. completion 2011-12 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT01603030

    Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation

    Not yet reported Adapt Produtos Oftalmológicos Ltda. 66 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Eye Infection/Inflammation Other
    View official trial listing →
  • Completed NCT NCT01606436

    A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia

    Not yet reported Denovo Biopharma LLC 86 participants Est. completion 2012-09 8 sites
    Other conditions: Schizophrenic Disorders
    View official trial listing →
  • Completed NCT NCT01620307

    Rapamune Improves Outcomes of Severe H1N1 Pneumonia

    Not yet reported Chang Gung Memorial Hospital 38 participants Est. completion 2011-12
    Other conditions: H1N1 Pneumonia, Hypoxemia
    View official trial listing →
  • Completed NCT NCT01642485

    Food and Insulin Effect on QT/QTC Interval of ECG

    Not yet reported Richmond Pharmacology Limited 32 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Effects of Different Meals on the QT/QTc Interval, Insulin and Oral Hypoglycemic [Antidiabetic] Drugs Causing Adverse Effects in Therapeutic Use, C-Peptide Effects on the QT/QTc Interval, Moxifloxacin ECG Profile in Fed and Fasted State, Japanese vs. Caucasian TQT Comparison
    View official trial listing →
  • Completed NCT NCT01643889

    A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers

    Not yet reported Janssen Research & Development, LLC 44 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01653990

    Moxifloxacin_QT Study in Chinese Healthy Volunteer

    Not yet reported Peking University Third Hospital 36 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: QT Interval Prolongation
    View official trial listing →
  • Completed NCT NCT01660204

    Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections

    Not yet reported UMC Utrecht 2283 participants Est. completion 2014-01 7 sites
    Other conditions: Community-acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT01674218

    Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 74 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01689116

    Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers

    Not yet reported Biogen 179 participants Est. completion 2012-11-30 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01690533

    Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory Disease

    Bayer 497 participants Est. completion 2013-07-19 1 site
    Other conditions: Anti-Infective Agents
    View official trial listing →
  • Completed NCT NCT01702376

    This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

    Not yet reported GlaxoSmithKline 52 participants Est. completion 2013-01-14 1 site Stand-alone
    Other conditions: Obstetric Labour, Premature
    View official trial listing →
  • Withdrawn NCT NCT01721135

    A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.

    Not yet reported GlaxoSmithKline Est. completion 2014-12 1 site Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01743677

    CP-690,550 Thorough QTc Study

    Not yet reported Pfizer 60 participants Est. completion 2008-02-09 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01756495

    A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

    Not yet reported GlaxoSmithKline 56 participants Est. completion 2013-04-23 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01762839

    A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants

    Not yet reported Melinta Therapeutics, Inc. 150 participants Est. completion 2013-02-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01775761

    A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

    Not yet reported Pfizer 42 participants Est. completion 2013-04 3 sites Stand-alone
    Other conditions: TTR Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01787357

    A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01790087

    ANX-188 Thorough QT/QTc Study in Healthy Volunteers

    Not yet reported Mast Therapeutics, Inc. 72 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01792700

    Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

    Not yet reported Seoul National University Bundang Hospital 648 participants Est. completion 2010-12 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT01799356

    Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

    Not yet reported Istanbul Bakirkoy Maternity and Children Diseases Hospital 1303 participants Est. completion 2013-03 4 sites
    Other conditions: Pelvic Inflammatory Disease
    View official trial listing →
  • Withdrawn NCT NCT01803399

    A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

    Not yet reported GlaxoSmithKline Est. completion 2014-12
    Other conditions: Infections, Bacterial
    View official trial listing →
  • Completed NCT NCT01811225

    Smoking, Sex Hormones, and Pregnancy

    Not yet reported University of Minnesota 95 participants Est. completion 2017-06 1 site
    Other conditions: Nicotine Dependence, Contraception
    View official trial listing →
  • Completed NCT NCT01839279

    A Study to Define the ECG Effects of Tizanidine Compared to Placebo and the Positive Control, Moxifloxacin, in Healthy Men and Women Using a Blinded ECG Evaluator: A Thorough ECG Trial

    Not yet reported Acorda Therapeutics 136 participants Est. completion 2014-05 1 site
    Other conditions: Spasticity
    View official trial listing →
  • Completed NCT NCT01854710

    ADASUVE 2-dose Thorough QT/QTc Study

    Not yet reported Alexza Pharmaceuticals, Inc. 60 participants Est. completion 2013-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01859702

    Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients

    Not yet reported Alcon Research 36 participants Est. completion 2012-08 Stand-alone
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT01862887

    A Study to Investigate the Effect of PH-797804 on QTc Interval

    Not yet reported Pfizer 48 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01874314

    Effects of SQ109 on QTc Interval in Healthy Subjects

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2015-12 1 site
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT01874561

    Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

    Not yet reported Achieve Life Sciences 155 participants Est. completion 2014-01 1 site
    Other conditions: Cardiac Conduction and Repolarization
    View official trial listing →
  • Completed NCT NCT01876316

    The Effect of Ethnic on Moxifloxacin Induced QT Interval Prolongation in Korean and Japanese Healthy Subjects

    Not yet reported Inje University 40 participants Est. completion 2013-01
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01881438

    An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment

    Janssen Research & Development, LLC 119924 participants Est. completion 2013-05
    Other conditions: Retinal Detachment
    View official trial listing →
  • Completed NCT NCT01910415

    Phase 1, QT/QTC Interval Study in Healthy Subjects

    Not yet reported Vertex Pharmaceuticals Incorporated 200 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Terminated NCT NCT01928693

    A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.

    Not yet reported Cornea Consultants Of Nashville 2 participants Est. completion 2014-05 1 site
    Other conditions: Corneal Ulcers
    View official trial listing →
  • Completed NCT NCT01928914

    Tafenoquine Thorough QTc Study in Healthy Subjects

    Not yet reported GlaxoSmithKline 260 participants Est. completion 2012-06-04 2 sites Stand-alone
    Other conditions: Malaria, Vivax
    View official trial listing →
  • Terminated NCT NCT01936480

    Genetics of QT Response to Moxifloxacin

    Not yet reported Massachusetts General Hospital 51 participants Est. completion 2019-06-19 1 site Stand-alone
    Other conditions: Cardiac Arrhythmias
    View official trial listing →
  • Completed NCT NCT01941446

    A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

    Not yet reported Tetraphase Pharmaceuticals, Inc 54 participants Est. completion 2013-07 Stand-alone
    Other conditions: Normal Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01944774

    Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride

    Not yet reported TaiGen Biotechnology Co., Ltd. 207 participants Est. completion 2013-12 2 sites
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT01965431

    Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

    Not yet reported Boehringer Ingelheim 48 participants Est. completion 2014-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01968733

    Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

    Not yet reported Melinta Therapeutics, Inc. 863 participants Est. completion 2015-09 270 sites
    Other conditions: Community-acquired Bacterial Pneumonia
    View official trial listing →
  • Completed NCT NCT01983839

    PK Analysis of Moxifloxacin in the Treatment of CAP

    University of Aarhus 18 participants Est. completion 2014-10 1 site
    Other conditions: Pneumonia
    View official trial listing →
  • Completed NCT NCT01984827

    Effect of Glucose on QTc Interval in Type 1 Diabetes

    Not yet reported Richmond Research Institute 24 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01999114

    The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

    Not yet reported Purdue Pharma LP 328 participants Est. completion 2012-10 1 site
    Other conditions: ECG Effects
    View official trial listing →
  • Completed NCT NCT02016157

    Moxifloxacin in Situ Gel to Treat Periodontal Pocket.

    Not yet reported Sri Hasanamba Dental College and Hospital 5 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Chronic Generalized Periodontitis
    View official trial listing →
  • Terminated NCT NCT02031588

    Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.

    Assistance Publique - Hôpitaux de Paris 77 participants Est. completion 2015-09 1 site
    Other conditions: Bacterial Infections
    View official trial listing →
  • Completed NCT NCT02056392

    To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers

    Not yet reported AstraZeneca 54 participants Est. completion 2014-08 1 site
    Other conditions: Solid Tumours
    View official trial listing →
  • Completed NCT NCT02062203

    Effect of AKB-6548 on Cardiac Repolarization Intervals in Healthy Volunteers

    Not yet reported Akebia Therapeutics 50 participants Est. completion 2014-04 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02064348

    A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

    Not yet reported Novo Nordisk A/S 168 participants Est. completion 2015-04-23 1 site Mixed
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02068170

    Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

    KU Leuven 178 participants Est. completion 2015-06 1 site
    Other conditions: Delirium, QT-prolongation
    View official trial listing →
  • Completed NCT NCT02073084

    A Thorough Corrected QT Interval Trial

    Not yet reported Kowa Research Institute, Inc. 56 participants 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02080468

    Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

    Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-04-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02084953

    Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 59 participants Est. completion 2014-05 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02091310

    Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

    Not yet reported Genfit 200 participants Est. completion 2015-02 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02098486

    Comparisons of Intravenous Ceftriaxone With Intravenous Moxifloxacin in ERCP

    Not yet reported Kangbuk Samsung Hospital 86 participants Est. completion 2015-09 1 site
    Other conditions: Cholangitis
    View official trial listing →
  • Terminated NCT NCT02099240

    Patients Response to Early Switch To Oral:Osteomyelitis Study

    Not yet reported Julio Ramirez 11 participants Est. completion 2018-11-07 1 site
    Other conditions: Osteomyelitis
    View official trial listing →
  • Completed NCT NCT02104648

    A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

    Not yet reported Hoffmann-La Roche 203 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02114684

    Improving Retreatment Success (IMPRESS)

    Not yet reported, Not yet reported Centre for the AIDS Programme of Research in South Africa 197 participants Est. completion 2017-07-17 1 site
    Other conditions: Recurrent Tuberculosis
    View official trial listing →
  • Completed NCT NCT02117830

    A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects

    Not yet reported Repros Therapeutics Inc. 54 participants
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02119091

    Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers

    Not yet reported Haiyan Li 80 participants Est. completion 2014-12 2 sites Stand-alone
    Other conditions: Cardiac Toxicity
    View official trial listing →
  • Completed NCT NCT02127593

    A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities

    Not yet reported Janssen Research & Development, LLC 101 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02128308

    Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

    Not yet reported Seoul National University Hospital 16 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02136888

    Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects

    Not yet reported Actelion 116 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02144246

    Contraceptive Hormones and Women With Cystic Fibrosis

    Not yet reported University of Pennsylvania 5 participants 1 site
    Other conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception
    View official trial listing →
  • Completed NCT NCT02152332

    A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants

    Not yet reported Janssen Research & Development, LLC 64 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02155205

    A Thorough QT Study of Telotristat Etiprate

    Not yet reported Lexicon Pharmaceuticals 48 participants 1 site
    Other conditions: QT Interval
    View official trial listing →
  • Completed NCT NCT02157467

    Study of Combined Oral Contraceptive Effects in Female Subjects

    Not yet reported ViiV Healthcare 46 participants Est. completion 2014-08-25
    Other conditions: Infection, Human Immunodeficiency Virus
    View official trial listing →
  • Completed NCT NCT02164812

    Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: HIV/AIDS
    View official trial listing →
  • Completed NCT NCT02165332

    A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval

    Not yet reported Hoffmann-La Roche 64 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02172144

    Via Respimat® Inhaled BI 1744 CL Compared to Moxifloxacin and Placebo in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 24 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02183467

    Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects

    Not yet reported Boehringer Ingelheim 44 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02206204

    Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

    Not yet reported Actelion 159 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Cardiodynamics, Safety, Tolerability, Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT02213029

    A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

    Not yet reported GlaxoSmithKline 33 participants Est. completion 2016-02-07 2 sites
    Other conditions: Embryo Transfer
    View official trial listing →
  • Completed NCT NCT02217930

    Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers

    Not yet reported Wockhardt 80 participants Est. completion 2015-07 1 site
    Other conditions: Qt Interval, Variation in
    View official trial listing →
  • Completed NCT NCT02222324

    A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

    Not yet reported Eisai Inc. 60 participants Est. completion 2014-12 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02223702

    Alternative Antibiotic Regime in the Treatment of GAgP

    Not yet reported Kocaeli University 39 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Generalized Aggressive Periodontitis, Aggressive Periodontitis
    View official trial listing →
  • Completed NCT NCT02236026

    A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers

    Not yet reported Population Council 44 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02241759

    Study of the Electrocardiographic Effects of TA-8995

    Not yet reported Xention Ltd 136 participants Est. completion 2014-12 1 site
    Other conditions: Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT02243241

    The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

    Not yet reported Purdue Pharma LP 208 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02257398

    Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

    Not yet reported GlaxoSmithKline 55 participants Est. completion 2015-03-02 1 site Stand-alone
    Other conditions: Infections, Respiratory Tract
    View official trial listing →
  • Completed NCT NCT02262546

    Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 60 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02271438

    A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 28 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02283788

    Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization

    Not yet reported Bial - Portela C S.A. 67 participants Est. completion 2007-06 1 site Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02293148

    Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

    Not yet reported GlaxoSmithKline 61 participants Est. completion 2015-03-10 1 site Stand-alone
    Other conditions: Anaemia
    View official trial listing →
  • Completed NCT NCT02307864

    Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

    Not yet reported Janssen Scientific Affairs, LLC 68 participants Est. completion 2015-08-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02322619

    Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 26 participants Est. completion 2012-12 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02331823

    Research on New Regimens for Retreatment Pulmonary Tuberculosis

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 864 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Reinfection Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT02342886

    Shortening Treatment by Advancing Novel Drugs

    Not yet reported Global Alliance for TB Drug Development 284 participants Est. completion 2018-05 26 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Drug Sensitive, Tuberculosis, Pulmonary, Multi Drug-resistant
    View official trial listing →
  • Completed NCT NCT02349685

    The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

    Not yet reported Seoul National University Bundang Hospital 219 participants Est. completion 2014-06 Stand-alone
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Terminated NCT NCT02359331

    The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

    Not yet reported Seoul National University Bundang Hospital 370 participants Est. completion 2022-12-01 1 site Stand-alone
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Completed NCT NCT02409290

    The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

    Not yet reported IUATLD, Inc 588 participants Est. completion 2023-05-02 13 sites
    Other conditions: MDR-TB
    View official trial listing →
  • Completed NCT NCT02410772

    TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

    Not yet reported Centers for Disease Control and Prevention 2516 participants Est. completion 2021-05 33 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02436486

    Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

    Not yet reported H. Lundbeck A/S 76 participants 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02454205

    An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

    Not yet reported, Not yet reported University of Cape Town 154 participants Est. completion 2021-08-30 1 site
    Other conditions: Tuberculosis, Multidrug Resistant Tuberculosis, Extensively-drug Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT02479308

    A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers

    Not yet reported Alkermes, Inc. 129 participants Est. completion 2015-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02494609

    Oral Contraceptive DDI Study

    Not yet reported Lexicon Pharmaceuticals 30 participants 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02496572

    Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

    Medecins Sans Frontieres, Netherlands 110 participants Est. completion 2016-04 1 site
    Other conditions: Multidrug Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT02508753

    Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects

    Not yet reported Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 52 participants Est. completion 2010-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02515045

    Dropless vs. Standard Drops Contralateral Eye Study

    Not yet reported Carolina Eyecare Physicians, LLC 59 participants Est. completion 2016-03 4 sites
    Other conditions: Cataract
    View official trial listing →
  • Completed NCT NCT02515864

    Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

    Not yet reported Fuji Yakuhin Co., Ltd. 48 participants Est. completion 2016-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02533427

    Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

    Not yet reported Gilead Sciences 15 participants Est. completion 2016-03-18 1 site
    Other conditions: HCV Infection
    View official trial listing →
  • Completed NCT NCT02537288

    A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval

    Not yet reported Vantia Ltd 43 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02559310

    Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

    Not yet reported Nabriva Therapeutics AG 551 participants Est. completion 2017-05 99 sites
    Other conditions: Community Acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT02563327

    Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

    Not yet reported Centers for Disease Control and Prevention 2516 participants Est. completion 2021-08-30 3 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT02581072

    A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

    Not yet reported Novan, Inc. 56 participants Est. completion 2016-04 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT02589782

    Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

    Not yet reported, Not yet reported Medecins Sans Frontieres, Netherlands 552 participants Est. completion 2022-08-05 7 sites Stand-alone
    Other conditions: Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT02625467

    Treatment of Keratoconus With PALK Versus PK

    Not yet reported Instituto de Oftalmología Fundación Conde de Valenciana 28 participants Est. completion 2015-11 Stand-alone
    Other conditions: Keratoconus
    View official trial listing →
  • Completed NCT NCT02658825

    A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 66 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02661594

    Thorough QT Study of Intravenous Amisulpride

    Not yet reported Acacia Pharma Ltd 40 participants Est. completion 2014-03 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02679573

    Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia

    Not yet reported Melinta Therapeutics, Inc. 860 participants Est. completion 2018-08-07 90 sites
    Other conditions: Community Acquired Bacterial Pneumonia
    View official trial listing →
  • Completed NCT NCT02680080

    Effect of Grapefruit on QT Interval in Healthy Volunteers and Patients With Congenital Long QT Syndrome

    Not yet reported Tel-Aviv Sourasky Medical Center 25 participants Est. completion 2019-05-22 1 site
    Other conditions: Long QT Syndrome
    View official trial listing →
  • Completed NCT NCT02717871

    Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis

    Not yet reported University Hospital, Geneva 35 participants Est. completion 2020-10 1 site
    Other conditions: Keratitis; Infectious Disease (Manifestation)
    View official trial listing →
  • Completed NCT NCT02735603

    Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

    Not yet reported Orexigen Therapeutics, Inc 84 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Heart Repolarization
    View official trial listing →
  • Completed NCT NCT02737605

    A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 62 participants Est. completion 2017-02-23 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02754765

    Evaluating Newly Approved Drugs for Multidrug-resistant TB

    Not yet reported Médecins Sans Frontières, France 754 participants Est. completion 2023-06 12 sites Stand-alone
    Other conditions: Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses
    View official trial listing →
  • Completed NCT NCT02785770

    A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects

    Not yet reported Pfizer 44 participants Est. completion 2016-10-20 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02787057

    Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

    Not yet reported Peking University First Hospital 80 participants Est. completion 2016-04
    Other conditions: Peritoneal Dialysis Associated Peritonitis
    View official trial listing →
  • Completed NCT NCT02792517

    Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females

    Not yet reported Amgen 41 participants Est. completion 2016-09-09 4 sites
    Other conditions: Headache, Migraine
    View official trial listing →
  • Completed NCT NCT02800785

    The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

    Not yet reported University of Washington 1552 participants Est. completion 2021-09-01 25 sites
    Other conditions: Appendicitis
    View official trial listing →
  • Completed NCT NCT02807207

    To Evaluate the Cardiac Safety and PK Following a Single Oral Dose Administration of Pacritinib in Healthy Subjects

    Not yet reported CTI BioPharma 42 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02813694

    Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia

    Not yet reported Nabriva Therapeutics AG 738 participants Est. completion 2018-01 155 sites
    Other conditions: Community Acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT02816853

    Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Chinese Healthy Participants

    Not yet reported Janssen Research & Development, LLC 44 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02816905

    Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery

    Not yet reported Cairo University 40 participants Est. completion 2016-06 1 site
    Other conditions: Intraocular Pressure
    View official trial listing →
  • Completed NCT NCT02820311

    Thorough QT (TQT) Study of TD-4208 in Healthy Subjects

    Not yet reported Mylan Inc. 48 participants Est. completion 2016-07 1 site
    Other conditions: Cardiac Repolarization in Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02833831

    Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 103 participants Est. completion 2017-02-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02865876

    Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis

    Not yet reported Instituto de Oftalmología Fundación Conde de Valenciana 264 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Keratitis
    View official trial listing →
  • Completed NCT NCT02903836

    Phase II Study of Oral Nafithromycin in CABP

    Not yet reported Wockhardt 231 participants Est. completion 2017-07-08 6 sites
    Other conditions: Community-Acquired Bacterial Pneumonia (CABP)
    View official trial listing →
  • Completed NCT NCT02910635

    A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

    Not yet reported Ionis Pharmaceuticals, Inc. 52 participants Est. completion 2016-12-20 1 site
    Other conditions: Abnormalities, Cardiovascular
    View official trial listing →
  • Completed NCT NCT02911870

    A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.

    Not yet reported Novo Nordisk A/S 84 participants Est. completion 2017-05-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02917200

    Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

    Not yet reported Da Volterra 150 participants Est. completion 2016-12-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02924337

    Effect of Imeglimin on QT/QTc Intervals in Healthy Subjects

    Not yet reported Poxel SA 55 participants Est. completion 2016-12 1 site
    Other conditions: Qt Interval, Variation in
    View official trial listing →
  • Completed NCT NCT02980523

    Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)

    Not yet reported Laboratorios Sophia S.A de C.V. 150 participants Est. completion 2017-05 1 site
    Other conditions: Bacterial Conjunctivitis
    View official trial listing →
  • Completed NCT NCT03162900

    A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects

    Not yet reported Pfizer 36 participants Est. completion 2017-10-16 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03164109

    A Phase 1, Randomized, Placebo-and Positive-Controlled Crossover Study to Determine the Effect of Single-Dose GC4419 on QTc Interval in Healthy Volunteers

    Not yet reported Galera Therapeutics, Inc. 28 participants Est. completion 2017-10-13 1 site
    Other conditions: Healthy Volunteers, Healthy
    View official trial listing →
  • Completed NCT NCT03187301

    A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

    Not yet reported Sumitomo Pharma America, Inc. 48 participants Est. completion 2017-12-21 15 sites
    Other conditions: Parkinson's Disease, Off Episodes of Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03236961

    Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis

    Not yet reported Turku University Hospital 552 participants Est. completion 2029-04-01 1 site
    Other conditions: Acute Appendicitis
    View official trial listing →
  • Not yet recruiting NCT NCT03244072

    Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

    Not yet reported, Not yet reported Jason Ahee, M.D. 60000 participants Est. completion 2031-10 1 site
    Other conditions: Endophthalmitis
    View official trial listing →
  • Completed NCT NCT03258515

    A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

    Not yet reported AstraZeneca 45 participants Est. completion 2018-03-24 1 site Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT03280004

    Reason Evaluation of Initial Treatment Failure in Patients With CAP

    Peking Union Medical College Hospital 314 participants Est. completion 2019-11-30 1 site
    Other conditions: Community-acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT03338621

    Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

    Not yet reported, Not yet reported Global Alliance for TB Drug Development 455 participants Est. completion 2022-06-10 26 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR, Tuberculosis, Drug-Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT03362853

    A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

    Not yet reported TaiGen Biotechnology Co., Ltd. 48 participants Est. completion 2012-08-10 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03363295

    Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis

    Not yet reported Universidade Federal de Pernambuco 120 participants Est. completion 2019-12-30 1 site Stand-alone
    Other conditions: Endophthalmitis, Macula Edema, Cataract
    View official trial listing →
  • Completed NCT NCT03432884

    A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

    Not yet reported BeiGene 40 participants Est. completion 2018-04-16 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03465436

    A Study of Lasmiditan on the Heart in Healthy Participants

    Not yet reported Eli Lilly and Company 56 participants Est. completion 2011-12-20 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03491995

    A Unique Regimen for Treatment of Helicobacter Pylori Infection

    Not yet reported Sherief Abd-Elsalam 600 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT03541564

    An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

    Not yet reported Bristol-Myers Squibb 84 participants Est. completion 2018-09-04 1 site
    Other conditions: Systemic Lupus Erythematosus, Healthy Participants
    View official trial listing →
  • Completed NCT NCT03554304

    Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

    Not yet reported Wockhardt 60 participants Est. completion 2017-10-06 1 site Stand-alone
    Other conditions: QT/QTc Interval in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03564158

    Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers

    Not yet reported Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 53 participants Est. completion 2018-11-19 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03577275

    A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

    Not yet reported NorthSea Therapeutics B.V. 32 participants Est. completion 2018-09-24 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03604848

    NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB

    Not yet reported Huashan Hospital 488 participants Est. completion 2024-08-04 12 sites Stand-alone
    Other conditions: Multidrug Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT03606057

    A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)

    Not yet reported Janssen Research & Development, LLC 188 participants Est. completion 2019-02-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03609099

    Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response

    Not yet reported David Garcia Cinca 424 participants Est. completion 2021-05-15 5 sites
    Other conditions: Community-acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT03613649

    Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 72 participants Est. completion 2019-01-02 1 site
    Other conditions: Electrocardiogram Repolarisation Abnormality, Gonococcal Infection
    View official trial listing →
  • Completed NCT NCT03634852

    A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

    Not yet reported Suzan A Rattan 1000 participants Est. completion 2018-02-01
    Other conditions: Endophthalmitis Postoperative
    View official trial listing →
  • Terminated NCT NCT03640650

    Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.

    Not yet reported PeriPharm 80 participants Est. completion 2021-03-16 2 sites Stand-alone
    Other conditions: Cataract Surgery
    View official trial listing →
  • Completed NCT NCT03656952

    A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers

    Not yet reported Pfizer 33 participants Est. completion 2019-02-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03657264

    Cardiac Safety Evaluation of P03277

    Not yet reported Guerbet 48 participants Est. completion 2018-06-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03657446

    A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

    Not yet reported Idorsia Pharmaceuticals Ltd. 36 participants Est. completion 2018-10-26 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03696459

    A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Participants

    Not yet reported Janssen Research & Development, LLC 52 participants Est. completion 2019-12-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03709927

    4-way Crossover QT Evaluation in Healthy Subjects

    Not yet reported Nabriva Therapeutics AG 41 participants Est. completion 2018-08-21 1 site
    Other conditions: Cardiac Repolarization in Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03777761

    Effects of Tucatinib on Cardiac Repolarization in Healthy Participants

    Not yet reported Seagen Inc. 55 participants Est. completion 2019-03-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03808298

    Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

    Not yet reported Hoffmann-La Roche 57 participants Est. completion 2019-07-13 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03830671

    The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

    Not yet reported Beijing Chest Hospital 515 participants Est. completion 2022-06-08 20 sites Stand-alone
    Other conditions: Multi-drug Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT03832452

    A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function

    Not yet reported Idorsia Pharmaceuticals Ltd. 44 participants Est. completion 2019-04-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03866369

    Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose

    Not yet reported Inventiva Pharma 36 participants Est. completion 2019-08-27 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03867136

    Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

    Not yet reported Huashan Hospital 354 participants Est. completion 2024-08-10 13 sites
    Other conditions: Multidrug Resistant Tuberculosis
    View official trial listing →
  • Completed NCT NCT03868657

    The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism

    Not yet reported Signe Torekov 44 participants Est. completion 2020-03-09 1 site
    Other conditions: Long QT Syndrome, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT03951402

    Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women

    Not yet reported Grünenthal GmbH 48 participants Est. completion 2003-08 1 site Stand-alone
    Other conditions: Prolonged QTc Interval, Pharmacokinetic
    View official trial listing →
  • Completed NCT NCT03959566

    PanACEA Sutezolid Dose-finding and Combination Evaluation

    Not yet reported Michael Hoelscher 75 participants Est. completion 2022-09-30 4 sites Stand-alone
    Other conditions: Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT03985410

    Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers

    Not yet reported Entasis Therapeutics 32 participants Est. completion 2019-07-24 1 site Stand-alone
    Other conditions: Acinetobacter Baumannii-calcoaceticus Complex Infections
    View official trial listing →
  • Completed NCT NCT04019652

    The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

    Not yet reported Daiichi Sankyo 55 participants Est. completion 2015-12-23 1 site Stand-alone
    Other conditions: Hypertension, Mineralocorticoid Receptor Antagonist
    View official trial listing →
  • Completed NCT NCT04039204

    Elagolix for Fertility Enhancement Clinical Trial

    Not yet reported Wake Forest University Health Sciences 10 participants Est. completion 2023-08-09 1 site
    Other conditions: Endometriosis, Unexplained Infertility
    View official trial listing →
  • Status unknown NCT NCT04081077

    PRACTECAL-PKPD Sub Study

    Not yet reported, Not yet reported Medecins Sans Frontieres, Netherlands 240 participants Est. completion 2022-09-30 5 sites Stand-alone
    Other conditions: Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT04083833

    A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects

    Not yet reported Wex Pharmaceuticals Inc. 25 participants Est. completion 2018-03-24 1 site Stand-alone
    Other conditions: TQT Study
    View official trial listing →
  • Completed NCT NCT04097730

    Steroids and Cross-linking for Ulcer Treatment

    Not yet reported Thomas M. Lietman 280 participants Est. completion 2024-09-18 3 sites Stand-alone
    Other conditions: Keratitis Bacterial
    View official trial listing →
  • Terminated NCT NCT04126343

    A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants

    Not yet reported UCB Biopharma S.P.R.L. 54 participants Est. completion 2020-05-22 1 site
    Other conditions: Healthy Study Participants
    View official trial listing →
  • Status unknown NCT NCT04168723

    TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects

    Not yet reported MedDay Pharmaceuticals SA 64 participants Est. completion 2020-03-05 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04172987

    A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-02-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04179500

    A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

    Not yet reported Global Alliance for TB Drug Development 26 participants Est. completion 2024-07-17 4 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR, Tuberculosis, Drug-Resistant Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT04187469

    Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 286 participants Est. completion 2024-02-01 1 site Stand-alone
    Other conditions: Pulmonary Tuberculosis
    View official trial listing →
  • Withdrawn NCT NCT04204122

    Vigamox Treatment for Ocular Graft-Versus-Host Disease

    Not yet reported Washington University School of Medicine Est. completion 2025-03-31
    Other conditions: Ocular Graft-versus-host Disease
    View official trial listing →
  • Status unknown NCT NCT04212429

    The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

    Not yet reported, Not yet reported National University of Malaysia 128 participants Est. completion 2022-05 1 site
    Other conditions: Endophthalmitis Postoperative
    View official trial listing →
  • Status unknown NCT NCT04214821

    The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

    Not yet reported, Not yet reported National University of Malaysia 128 participants Est. completion 2022-05 2 sites
    Other conditions: Endophthalmitis
    View official trial listing →
  • Completed NCT NCT04225078

    A Study to Evaluate the Effects of Loperamide (JNJ-289679) on Electrocardiogram Intervals in Healthy Adult Participants

    Not yet reported Janssen Research & Development, LLC 66 participants Est. completion 2022-01-12 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04238195

    A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects

    Not yet reported Spero Therapeutics 24 participants Est. completion 2020-02-26 1 site
    Other conditions: TQT Study
    View official trial listing →
  • Completed NCT NCT04250506

    A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

    Not yet reported Idorsia Pharmaceuticals Ltd. 36 participants Est. completion 2020-07-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04255277

    To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

    Not yet reported Viatris Innovation GmbH 97 participants Est. completion 2021-10-18 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT04281342

    To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

    Not yet reported Idorsia Pharmaceuticals Ltd. 48 participants Est. completion 2021-09-03 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT04342273

    A Through QT/QTc Study of KW-6356

    Not yet reported Kyowa Kirin Co., Ltd. 128 participants Est. completion 2020-09-05 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04423068

    Inpatient Adolescent Contraception

    Not yet reported Children's Mercy Hospital Kansas City 25 participants Est. completion 2023-04-04 1 site
    Other conditions: Pregnancy Related, Contraception, Contraceptive Usage, Contraception Behavior, Pregnancy
    View official trial listing →
  • Completed NCT NCT04423744

    Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants

    Not yet reported Bayer 42 participants Est. completion 2021-01-21 1 site Stand-alone
    Other conditions: Cough, Endometriosis, Overactive Bladder
    View official trial listing →
  • Completed NCT NCT04457063

    Endothelial Cell Loss After Penetrating Keratoplasty

    Not yet reported, Not yet reported Alexandria University 8 participants Est. completion 2020-06-15 1 site
    Other conditions: Keratoconus
    View official trial listing →
  • Completed NCT NCT04464291

    An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years

    Not yet reported The Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) 500 participants Est. completion 2021-01-31 1 site Stand-alone
    Other conditions: Pneumonia, Pneumococcal, Invasive Pneumococcal Disease, Acute Otitis Media
    View official trial listing →
  • Completed NCT NCT04521140

    Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

    Not yet reported Nicole Fram M.D. 36 participants Est. completion 2023-01-04 1 site Stand-alone
    Other conditions: Corneal Edema, Corneal Defect, Corneal Transplant, Penetrating KeratoPlasty, Anterior Chamber Inflammation, Ocular Pain, Intraocular Pressure
    View official trial listing →
  • Status unknown NCT NCT04545788

    Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

    Not yet reported Beijing Chest Hospital 200 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT04550832

    PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)

    Not yet reported LigaChem Biosciences, Inc. 76 participants Est. completion 2023-09-11 5 sites Stand-alone
    Other conditions: Infections and Infestations, Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT04560816

    A Study of the Cardiac Effects of ALXN1840 in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 57 participants Est. completion 2021-03-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04563845

    Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin

    Not yet reported ViiV Healthcare 50 participants Est. completion 2021-10-30 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT04660890

    A Study of the Cardiac Effects of ALXN2050 in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 39 participants Est. completion 2021-03-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04692623

    EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY

    Not yet reported Shaheed Benazir Bhutto University Sheringal Dir Upper 25 participants Est. completion 2021-04-01 1 site Stand-alone
    Other conditions: Blood Glucose, Low, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT04718636

    A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Participants

    Not yet reported Celgene 28 participants Est. completion 2021-08-03 3 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04724044

    Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

    Not yet reported Hellenic Institute for the Study of Sepsis 278 participants Est. completion 2023-04-11 18 sites
    Other conditions: Community-acquired Pneumonia, Sepsis, Inflammatory Response, Mortality, Biomarkers, SIRS
    View official trial listing →
  • Completed NCT NCT04750655

    Antibiotic Resistance In Eye Surgeries

    Not yet reported University of California, San Francisco 108 participants Est. completion 2023-08-31 1 site
    Other conditions: Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome
    View official trial listing →
  • Completed NCT NCT04779242

    Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

    Not yet reported Paratek Pharmaceuticals Inc 670 participants Est. completion 2024-03-27 55 sites
    Other conditions: Community-acquired Pneumonia, Bacterial Pneumonia
    View official trial listing →
  • Completed NCT NCT04795479

    T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers

    Not yet reported Corcept Therapeutics 36 participants Est. completion 2021-07-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04818229

    A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects

    Not yet reported Connect Biopharma Australia Pty Ltd 112 participants Est. completion 2022-03-30 2 sites
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT04821063

    Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval

    Not yet reported Italfarmaco 31 participants Est. completion 2021-06-18 1 site
    Other conditions: Duchenne and Becker Muscular Dystrophy, Polycytemia Vera
    View official trial listing →
  • Completed NCT NCT04828824

    Premature Discontinuation of Contraceptive Implants

    Not yet reported University of Colorado, Denver 600 participants Est. completion 2025-11-12 1 site
    Other conditions: Contraception Behavior
    View official trial listing →
  • Status unknown NCT NCT04856644

    Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB

    Not yet reported Kaohsiung Veterans General Hospital. 333 participants Est. completion 2024-12-31 4 sites Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT04867980

    A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants

    Not yet reported Acerta Pharma BV 48 participants Est. completion 2016-05-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04873323

    A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

    Not yet reported Taisho Pharmaceutical Co., Ltd. 59 participants Est. completion 2021-09-28 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT04879030

    Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD

    Not yet reported, Not yet reported Haiphong University of Medicine and Pharmacy 170 participants Est. completion 2020-12-30 1 site
    Other conditions: COPD Exacerbation Acute
    View official trial listing →
  • Status unknown NCT NCT04898907

    Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

    Not yet reported Angion Biomedica Corp 48 participants Est. completion 2021-09 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT05016206

    A Study of the Cardiac Effects of Danicopan in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 33 participants Est. completion 2018-10-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05027893

    Complications After Lower Third Molar Surgery

    Not yet reported University of Novi Sad 157 participants Est. completion 2023-12-31 1 site
    Other conditions: Postoperative Complications, Antibiotic Reaction, Antibiotic Side Effect, Antibiotic Resistant Infection, Antibiotic Resistant Strain, Infection, Bacterial, Infection, Laboratory
    View official trial listing →
  • Completed NCT NCT05046132

    Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

    Not yet reported Rhythm Pharmaceuticals, Inc. 77 participants Est. completion 2022-04-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05047055

    Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

    Tuberculosis Research Centre, India 550 participants Est. completion 2026-04-17 1 site
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT05061472

    A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity

    University of Colorado, Denver 20 participants Est. completion 2023-08-23 2 sites
    Other conditions: Contraceptive Usage, Overweight or Obesity, Body Weight Changes, Appetitive Behavior, Eating Behavior
    View official trial listing →
  • Status unknown NCT NCT05079854

    Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis

    Not yet reported Federal University of São Paulo 100 participants Est. completion 2023-11-01 1 site
    Other conditions: Endophthalmitis, Trauma, Corneal
    View official trial listing →
  • Completed NCT NCT05114720

    Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

    Not yet reported Sun Yat-sen University 559 participants Est. completion 2025-11-27 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05162625

    Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial

    Not yet reported University of Campinas, Brazil 100 participants Est. completion 2023-12-10 1 site
    Other conditions: Endophthalmitis, Open Globe Injury, Moxifloxacin, Post-Traumatic Endophthalmitis
    View official trial listing →
  • Completed NCT NCT05192369

    A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers

    Not yet reported Concert Pharmaceuticals 48 participants Est. completion 2022-01-28 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05241535

    Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects

    Not yet reported Tanabe Pharma America, Inc. 29 participants Est. completion 2022-02-27 2 sites Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT05255107

    Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers

    Not yet reported, Not yet reported Peschke GmbH 468 participants Est. completion 2024-02-24 12 sites Stand-alone
    Other conditions: Keratitis, Corneal Ulcer
    View official trial listing →
  • Completed NCT NCT05331664

    Dropless Pars Plana Vitrectomy Study

    Not yet reported Massachusetts Eye and Ear Infirmary 168 participants Est. completion 2026-08-30 1 site
    Other conditions: Rhegmatogenous Retinal Detachment
    View official trial listing →
  • Status unknown NCT NCT05331859

    Topical Insulin Versus Autologous Serum After Corneal Surgeries

    Not yet reported Benha University 250 participants Est. completion 2022-09 2 sites
    Other conditions: Corneal Epithelial Wound
    View official trial listing →
  • Completed NCT NCT05382312

    Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

    Not yet reported GlaxoSmithKline 127 participants Est. completion 2025-05-27 1 site Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT05400369

    A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Not yet reported Daiichi Sankyo 140 participants Est. completion 2024-09-25 18 sites
    Other conditions: COPD Exacerbation Acute
    View official trial listing →
  • Completed NCT NCT05413980

    Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery

    Novartis Pharmaceuticals 102 participants Est. completion 2024-04-01 9 sites
    Other conditions: Post Operative Endophthalmitis
    View official trial listing →
  • Completed NCT NCT05428683

    Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery

    Not yet reported Emad Abdel Aal Saliem 84 participants Est. completion 2021-12-10 1 site
    Other conditions: Pharmacological Action
    View official trial listing →
  • Completed NCT NCT05478278

    An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

    Not yet reported Usona Institute 60 participants Est. completion 2023-08-09 1 site
    Other conditions: QTc Interval, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT05508776

    A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People

    Not yet reported JW Pharmaceutical 28 participants Est. completion 2022-12-28 1 site
    Other conditions: Healthy Volunteers, Cardiac Repolarisation
    View official trial listing →
  • Completed NCT NCT05566288

    Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers

    Not yet reported Achieve Life Sciences 27 participants Est. completion 2022-12-23 1 site Stand-alone
    Other conditions: Smoking Cessation
    View official trial listing →
  • Completed NCT NCT05580003

    A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People

    Not yet reported Pfizer 94 participants Est. completion 2023-09-15 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05630872

    Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 2025-11-12 4 sites Stand-alone
    Other conditions: HIV-associated Tuberculosis
    View official trial listing →
  • Completed NCT NCT05655689

    The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study

    Alexandria University 123 participants Est. completion 2023-01-01 1 site
    Other conditions: Bacterial Keratitis, Fungal Keratitis, Mixed Bacterial and Fungal Keratitis, Microbial Keratitis
    View official trial listing →
  • Status unknown NCT NCT05665270

    A Study for Post op Inflammation After Cataract Surgery

    Not yet reported Wyse Eyecare 40 participants Est. completion 2023-12-15 1 site Stand-alone
    Other conditions: Cataract
    View official trial listing →
  • Terminated NCT NCT05668936

    A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

    Not yet reported AstraZeneca 31 participants Est. completion 2023-03-10 1 site Stand-alone
    Other conditions: Non-alcoholic Steatohepatitis
    View official trial listing →
  • Completed NCT NCT05671029

    Thorough QT/QTc of Pritelivir in Healthy Subjects

    Not yet reported AiCuris Anti-infective Cures AG 64 participants Est. completion 2023-05-18 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05716854

    Electrophysiological Effects of Potential QT Prolonging Drugs

    Not yet reported Food and Drug Administration (FDA) 44 participants Est. completion 2023-06-13 1 site
    Other conditions: Drug-induced QT Prolongation, Pharmacokinetics, Pharmacodynamics
    View official trial listing →
  • Completed NCT NCT05741632

    Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery

    Not yet reported Universitas Indonesia 68 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Cataract
    View official trial listing →
  • Terminated NCT NCT05758818

    A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects

    Not yet reported Rain Oncology Inc 6 participants Est. completion 2023-06-08 1 site
    Other conditions: Cardiac Repolarization
    View official trial listing →
  • Completed NCT NCT05830071

    A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

    Not yet reported Chiesi Farmaceutici S.p.A. 95 participants Est. completion 2023-10-13 1 site
    Other conditions: Asthma, Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT05867147

    An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 56 participants Est. completion 2023-06-14 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT05878522

    A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

    Not yet reported Pfizer 43 participants Est. completion 2023-10-30 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05893862

    A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)

    Not yet reported Merck Sharp & Dohme LLC 107 participants Est. completion 2024-02-22 4 sites Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05905484

    Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects

    Not yet reported Atea Pharmaceuticals, Inc. 35 participants Est. completion 2023-05-31 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Completed NCT NCT05924321

    A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

    Not yet reported Ferring Pharmaceuticals 40 participants Est. completion 2023-09-21 1 site
    Other conditions: Postpartum Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT05926466

    BTZ-043 Dose Evaluation in Combination and Selection

    Not yet reported Michael Hoelscher 90 participants Est. completion 2024-08 4 sites
    Other conditions: Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis
    View official trial listing →
  • Completed NCT NCT05927649

    A TQTc Study for Omaveloxolone

    Not yet reported Biogen 30 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Health Adult Subjects
    View official trial listing →
  • Completed NCT NCT05933447

    Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart

    Not yet reported Altavant Sciences GmbH 27 participants Est. completion 2023-07-28 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT05977868

    Comparing Oral Versus Parenteral Antimicrobial Therapy

    Not yet reported West Virginia University 94 participants Est. completion 2025-02-14 1 site
    Other conditions: Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection, Pulmonary Infection, Gastrointestinal Infection, Genitourinary Infection
    View official trial listing →
  • Completed NCT NCT05988034

    A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants

    Not yet reported Amgen 58 participants Est. completion 2020-03-31 1 site Stand-alone
    Other conditions: Electrocardiography
    View official trial listing →
  • Completed NCT NCT05995444

    A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects

    Not yet reported AN2 Therapeutics, Inc 24 participants Est. completion 2023-08-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06030219

    Microbiome Effect of Omadacycline on Healthy Volunteers

    Not yet reported University of Houston 32 participants Est. completion 2023-09-01 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06070597

    A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

    Not yet reported Boehringer Ingelheim 56 participants Est. completion 2024-06-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06102265

    Effect Of Reusing the Operative Supplies On Cataract Surgery and Climate Change

    Sohag University 2000 participants Est. completion 2023-11-01 2 sites
    Other conditions: Ophthalmopathy
    View official trial listing →
  • Completed NCT NCT06107036

    A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

    Not yet reported Boehringer Ingelheim 46 participants Est. completion 2024-07-25 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06162286

    A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

    Not yet reported Zai Lab (Hong Kong), Ltd. 100 participants Est. completion 2025-11-30 40 sites
    Other conditions: Community-acquired Bacterial Pneumonia
    View official trial listing →
  • Completed NCT NCT06163105

    The Effect of Gland Expression on the Regeneration of Meibomian Gland

    Not yet reported Chulalongkorn University 64 participants Est. completion 2025-03-06 1 site Stand-alone
    Other conditions: Meibomian Gland Dysfunction
    View official trial listing →
  • Completed NCT NCT06194032

    A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants

    Not yet reported AstraZeneca 28 participants Est. completion 2024-05-13 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06200467

    A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

    Not yet reported Boehringer Ingelheim 110 participants Est. completion 2025-10-22 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT06210269

    Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis

    Not yet reported Turku University Hospital 498 participants Est. completion 2045-12 9 sites
    Other conditions: Uncomplicated Acute Appendicitis
    View official trial listing →
  • Completed NCT NCT06215521

    A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants

    Not yet reported Eli Lilly and Company 31 participants Est. completion 2021-03-31 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06258265

    A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements

    Not yet reported Takeda 120 participants Est. completion 2024-07-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06352541

    Study Evaluating PRO-232 an Ophthalmic Solution Compared to Placebo.

    Not yet reported Laboratorios Sophia S.A de C.V. 28 participants Est. completion 2024-05-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06363292

    Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects

    Not yet reported Laboratorios Sophia S.A de C.V. 37 participants Est. completion 2024-05-28 1 site Stand-alone
    Other conditions: Ophthalmological Agent Toxicity, Bacterial Conjunctivitis
    View official trial listing →
  • Status unknown NCT NCT06427629

    Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device

    Not yet reported Seoul National University Hospital 148 participants Est. completion 2026-06 1 site
    Other conditions: Ocular Surface Disease
    View official trial listing →
  • Completed NCT NCT06462326

    A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers

    Not yet reported Zai Lab (Hong Kong), Ltd. 24 participants Est. completion 2024-09-29 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Not yet recruiting NCT NCT06526039

    A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

    Not yet reported Taipei Medical University WanFang Hospital 100 participants Est. completion 2029-12 Stand-alone
    Other conditions: Tuberculosis, Pulmonary
    View official trial listing →
  • Completed NCT NCT06589726

    A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 40 participants Est. completion 2024-12-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06591845

    Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

    Not yet reported Shanghai Ark Biopharmaceutical Co., Ltd. 34 participants Est. completion 2024-12-23 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06649942

    A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults

    Not yet reported Kaken Pharmaceutical 40 participants Est. completion 2025-03-24 1 site
    Other conditions: Healthy Volunteers - Male and Female
    View official trial listing →
  • Completed NCT NCT06746402

    A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

    Not yet reported Bristol-Myers Squibb 42 participants Est. completion 2025-09-11 2 sites Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06785090

    Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery

    Not yet reported Inas Abd 87 participants Est. completion 2024-01-31 1 site Stand-alone
    Other conditions: Cataract, Cystoid Macular Edema After Phacoemulsification
    View official trial listing →
  • Completed NCT NCT06795204

    Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

    Not yet reported Haisco-USA Pharmaceuticals, Inc. 48 participants Est. completion 2024-11-26 1 site
    Other conditions: Anesthesia; Adverse Effect, Cardiac Arrhythmia
    View official trial listing →
  • Completed NCT NCT06820307

    Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 50 participants Est. completion 2025-04-29 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT06837155

    A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects

    Not yet reported Taisho Pharmaceutical Co., Ltd. 52 participants Est. completion 2025-05-26 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06846866

    A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

    Not yet reported Bristol-Myers Squibb 74 participants Est. completion 2025-10-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06855264

    A Cardiac Liability Study of Varegacestat in Healthy Participants

    Not yet reported Immunome, Inc. 32 participants Est. completion 2025-05-06 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT07023029

    A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2025-09-22 1 site
    Other conditions: Healthy Volunteers, Sickle Cell Disease, Thalassemia
    View official trial listing →
  • Completed NCT NCT07063238

    A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

    Not yet reported Merck Sharp & Dohme LLC 42 participants Est. completion 2025-12-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07116915

    A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.

    Not yet reported Guangdong Hengrui Pharmaceutical Co., Ltd 85 participants Est. completion 2026-08-14 1 site
    Other conditions: COPD
    View official trial listing →
  • Not yet recruiting NCT NCT07126639

    A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

    Not yet reported Wuhan Pulmonary Hospital 200 participants Est. completion 2028-09-30 Stand-alone
    Other conditions: Efficacy and Safety
    View official trial listing →
  • Not yet recruiting NCT NCT07129629

    Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 45 participants Est. completion 2027-12-31 Stand-alone
    Other conditions: Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07191834

    A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

    Wuhan Pulmonary Hospital 60 participants Est. completion 2027-09-30
    Type 2 diabetes Other conditions: Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis, Pretomanid
    View official trial listing →
  • Completed NCT NCT07214935

    A TQT Study of Effect of M2951 on Cardiac Repolarization

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 36 participants Est. completion 2023-08-25 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07225699

    IN PATIENTS WITH CORNEAL ABRASIONS TREATED WITH COLLAGEN CORNEAL SHIELDS IN THE EMERGENCY DEPARTMENT SETTING

    Not yet reported Milton S. Hershey Medical Center 60 participants Est. completion 2029-01-30 Stand-alone
    Other conditions: Corneal Abrasions
    View official trial listing →
  • Completed NCT NCT07229157

    Effect of Maridebart Cafraglutide on the Heart's Electrical Activity

    Not yet reported Amgen 81 participants Est. completion 2026-08-27 2 sites Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07268664

    Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

    Not yet reported Beijing Chest Hospital 120 participants Est. completion 2028-08-31 3 sites Stand-alone
    Other conditions: Rifampicin Resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis, Drug-resistant Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07274020

    Long-Term Safety and Efficacy of Moxifloxacin in Bronchiectasis Patients

    Not yet reported Assiut University 140 participants Est. completion 2027-01-01 1 site Stand-alone
    Other conditions: Bronchiectasis, Non-Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT07305831

    A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)

    Not yet reported Merck Sharp & Dohme LLC 62 participants Est. completion 2026-04-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07308938

    Fluorometholone Study

    Not yet reported Vishal Jhanji 174 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Keratitis Bacterial, Corneal Ulcer (Diagnosis)
    View official trial listing →
  • Completed NCT NCT07378579

    An Investigational Study to Evaluate the Cardiac Safety Assessment (TQTc Study) of ESK-001

    Not yet reported Alumis Inc 52 participants Est. completion 2024-08-31 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Not yet recruiting NCT NCT07485010

    Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

    Not yet reported The University of Queensland 300 participants Est. completion 2031-07 Stand-alone
    Other conditions: Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections, Non-Tuberculous Mycobacteria Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT07513207

    A Study in Healthy People to Test How Vicadrostat Affects the Heart

    Not yet reported Boehringer Ingelheim 45 participants Est. completion 2026-08-21 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07559149

    Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis

    Not yet reported Gadjah Mada University 32 participants Est. completion 2025-08-14 1 site Stand-alone
    Other conditions: Infected Corneal Ulcers, CXL
    View official trial listing →
  • Not yet recruiting NCT NCT07585461

    Enhanced Treatment Strategy for Disseminated MAC Infection in HIV Patients: A Randomized Controlled Trial

    Not yet reported Shanghai Public Health Clinical Center 124 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Opportunistic Infections, HIV Related, Disseminated Mycobacterium Avium Complex Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07595042

    A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 900 participants Est. completion 2029-10-22 29 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07608172

    Short-Course Regimens for DS-PTB in AIDS Patients

    Not yet reported Shanghai Public Health Clinical Center 148 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: Tuberculosis in HIV-infected Individuals, Drug Susceptible Pulmonary Tuberculosis
    View official trial listing →
  • Not yet recruiting NCT NCT07668479

    Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan

    Public Union "Kazakhstan Association of Phthisiopulmonologists" 350 participants Est. completion 2027-08
    Other conditions: Tuberculosis, Tuberculosis Infection, Latent, Tuberculosis, Pulmonary, Drug Sensitive
    View official trial listing →
  • Active, not recruiting NCT NCT07708272

    QT Interval/Corrected QT Interval （QT/QTc） Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60 participants Est. completion 2027-02 1 site
    Other conditions: Myelofibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT07779629

    Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE)

    Not yet reported The First Affiliated Hospital of Shihezi University 350 participants Est. completion 2027-12 Stand-alone
    Osteoarthritis Other conditions: Brucellosis
    View official trial listing →
  • Not yet recruiting NCT NCT07792408

    Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives

    Not yet reported Vertex Pharmaceuticals Incorporated 148 participants Est. completion 2027-03-20
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Completed NCT NCT07812129

    Insulin Eye Drops and Epithelial Healing After Corneal Cross-linking

    Not yet reported, Not yet reported Cairo University 24 participants Est. completion 2025-05-30 1 site Stand-alone
    Other conditions: Corneal Epithelial Wound Healing, Post Operative Pain
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Moxifloxacin Hydrochloride, Moxifloxacin Hydrochloride Tablets, 400 mg, Moxifloxacin ophthalmic solution, Moxifloxacin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.